-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
nirmatrelvir
-
Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral [ME/CFS], 2025, Chia et al
Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome John K Chia, David Wang Background Etiology remains elusive for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and no treatment exists. Antivirals had no efficacy...- forestglip
- Thread
- enterovirus me/cfs nirmatrelvir remdesivir ritonavir
- Replies: 1
- Forum: ME/CFS research
-
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series, 2025, Cohen
https://www.nature.com/articles/s43856-024-00668-8 Article Open access Published: 06 January 2025 Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, Lisa Kava, Julia Moore Vogel, Julia...- Dolphin
- Thread
- nirmatrelvir
- Replies: 3
- Forum: Long Covid research